RT Journal Article
SR Electronic
T1 Functional Data Analysis: Transition from Daily Observation of COVID-19 Prevalence in France to Functional Curves
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.25.21264106
DO 10.1101/2021.09.25.21264106
A1 Oshinubi, Kayode
A1 Ibrahim, Firas
A1 Rachdi, Mustapha
A1 Demongeot, Jacques
YR 2021
UL http://medrxiv.org/content/early/2021/09/28/2021.09.25.21264106.abstract
AB In this paper we use the technique of functional data analysis to model daily hospitalized, deceased, ICU cases and return home patient numbers along the COVID-19 outbreak, considered as functional data across different departments in France while our response variables are numbers of vaccinations, deaths, infected, recovered and tests in France. These sets of data were considered before and after vaccination started in France. We used some smoothing techniques to smooth our data set, then analysis based on functional principal components method was performed, clustering using k-means techniques was done to understand the dynamics of the pandemic in different French departments according to their geographical location on France map and we also performed canonical correlations analysis between variables. Finally, we made some predictions to assess the accuracy of the method using functional linear regression models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data comes from public databasesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in public databases